Michael A Moso
Overview
Explore the profile of Michael A Moso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taiaroa G, Chibo D, Herman S, Taouk M, Gooey M, DCosta J, et al.
Lancet Reg Health West Pac
. 2024 Jul;
47:101103.
PMID: 38953059
Background: In Australia the incidence of HIV has declined steadily, yet sustained reduction of HIV transmission in this setting requires improved public health responses. As enhanced public health responses and...
2.
Kinsella P, Moso M, Morrissey C, Dendle C, Guy S, Bond K, et al.
Transpl Infect Dis
. 2024 May;
26(3):e14301.
PMID: 38809102
Antiviral agents with activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have played a critical role in disease management; however, little is known regarding the efficacy of these medications...
3.
Marsland M, Thomson T, OBrien H, Peach E, Bellette J, Humphreys N, et al.
Med J Aust
. 2024 May;
220(11):566-572.
PMID: 38803004
Objectives: To investigate the distribution and prevalence of Japanese encephalitis virus (JEV) antibody (as evidence of past infection) in northern Victoria following the 2022 Japanese encephalitis outbreak, seeking to identify...
4.
Moso M, Taiaroa G, Steinig E, Zhanduisenov M, Butel-Simoes G, Savic I, et al.
Lancet Microbe
. 2024 Feb;
5(4):e317-e325.
PMID: 38359857
Background: There has been high uptake of rapid antigen test device use for point-of-care COVID-19 diagnosis. Individuals who are symptomatic but test negative on COVID-19 rapid antigen test devices might...
5.
Moso M, Lim C, Williams E, Marshall C, McCarthy J, Williamson D
Lancet Infect Dis
. 2023 Sep;
24(2):e93-e105.
PMID: 37722397
There have been significant advances in the prevention and management of Ebola virus disease (EVD) caused by Zaire Ebola virus (ZEBOV), including the development of two effective vaccines, rVSV-ZEBOV and...
6.
Taouk M, Steinig E, Taiaroa G, Savic I, Tran T, Higgins N, et al.
J Med Virol
. 2023 Aug;
95(8):e29029.
PMID: 37565686
The impact and frequency of infectious disease outbreaks demonstrate the need for timely genomic surveillance to inform public health responses. In the largest known outbreak of mpox, genomic surveillance efforts...
7.
Moso M, Sasadeusz J, Morrissey C, Bond K, Guy S, Slavin M, et al.
Intern Med J
. 2023 Mar;
53(4):619-624.
PMID: 36929677
Coronavirus disease 2019 (COVID-19) in immunocompromised patients can lead to severe and prolonged illness. Data are limited with regard to management of COVID-19 in this setting, particularly in persistent or...
8.
Moso M, Williams E, Singh K, Lewin S, Williamson D
Pathology
. 2023 Feb;
55(5):740-742.
PMID: 36842873
No abstract available.
9.
Cronin K, Moso M, Chan E, Bond K
Curr Opin Infect Dis
. 2022 Oct;
35(6):524-529.
PMID: 36305373
Purpose Of Review: This review provides an update on recent findings about the clinical and microbiological characteristics of Staphylococcus lugdunensis . Recent Findings: European Committee on Antimicrobial Susceptibility Testing (EUCAST)...
10.
Moso M, Macesic N
Open Forum Infect Dis
. 2021 Jan;
8(1):ofaa525.
PMID: 33511220
No abstract available.